TrianglePUBLICATIONS · 35706488
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- EClinicalMedicine
- Publication date
- 2022 Jun
- First author
- Fennell DA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Fennell DA
- type
- Author
- name
- Porter C
- type
- Author
- name
- Lester J
- type
- Author
- name
- Danson S
- type
- Author
- name
- Taylor P
- type
- Author
- name
- Sheaff M
- type
- Author
- name
- Rudd RM
- type
- Author
- name
- Gaba A
- type
- Author
- name
- Busacca S
- type
- Author
- name
- Nixon L
- type
- Author
- name
- Gardner G
- type
- Author
- name
- Darlison L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Fennell DA
- type
- Author
- name
- Porter C
- type
- Author
- name
- Lester J
- type
- Author
- name
- Danson S
- type
- Author
- name
- Taylor P
- type
- Author
- name
- Sheaff M
- type
- Author
- name
- Rudd RM
- type
- Author
- name
- Gaba A
- type
- Author
- name
- Busacca S
- type
- Author
- name
- Nixon L
- type
- Author
- name
- Gardner G
- type
- Author
- name
- Darlison L
- type
- Author
- bibliography ids
- nci-bib-bccaa2481fb8eb1701d85fbb
- book metadata
- content sha256
- a11315aa8225ff39e37836955891f1b68c50610476c5c6e4e83bafcdc6f6be65
- document type
- citation
- dois
- 10.1016/j.eclinm.2022.101432
- electronic publication date
- display
- 2022 May 19
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35706488
- immutable id
- pubmed:35706488@a11315aa8225ff39e37836955891f1b68c50610476c5c6e4e83bafcdc6f6be65
- journal
- abbreviation
- EClinicalMedicine
- issn electronic
- 2589-5370
- issn print
- Source null
- issue
- Source null
- name
- EClinicalMedicine
- nlm unique id
- 101733727
- pages
- 101432
- volume
- 48
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35706488
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 0748656b6ee4a62d5d29b9289e15cc33dc723e0360a80d57ce0daf85aeaf4658
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Jun
- precision
- month
- year
- 2022
- publication types
- Journal Article
- record status
- PubMed
- schema version
- 1.0
- title
- Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.
Preserved source evidence · Not medical advice